Affini-T Therapeutics has filed a notice of an exempt offering of securities to raise $17,617,952.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Affini-T Therapeutics is raising up to $17,617,952.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Joseph Knowles played a…